<DOC>
	<DOCNO>NCT00378521</DOCNO>
	<brief_summary>The Purpose study determine response two different strength topical gel contain nitroglycerin patient Raynaud 's disease .</brief_summary>
	<brief_title>Dose Response Study Topical Gel Treatment Raynaud 's Phenomenon</brief_title>
	<detailed_description>The Purpose clinical study determine , control fashion , response two dosage strength topical gel formulation Nitroglycerin , MQX-503 , determination change finger blood flow skin temperature finger patient moderate severe primary Raynaud 's phenomenon Raynaud 's phenomenon secondary autoimmune disease , scleroderma . The dosage strength response treatment symptom ( pain , tingling , numbness ) also monitor .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Scleroderma , Systemic</mesh_term>
	<mesh_term>Scleroderma , Diffuse</mesh_term>
	<mesh_term>Autoimmune Diseases</mesh_term>
	<mesh_term>Raynaud Disease</mesh_term>
	<mesh_term>Nitroglycerin</mesh_term>
	<criteria>Outpatients , 18 75 year Clinical Diagnosis Raynaud 's , observed event study physician , symptom reduce blood flow meausred use laser doppler equipment Agree test gel apply finger Discontinue current vasodialator therapeis Raynaud 's treatment Four week last clinical trial participation Agree use investigational medication therapy treat Raynaud 's symptom participate study include dosage form nitroglycerin , isosorbide dinitrate , fenoldopam mesylate , milrinone lactate , nifedipine , diltiazem , felodipine , nimodipine , nisoldipine , verapamil Negative pregnancy test woman prior study start agree use effective contraception throughout Must able give write informed consent comply study requirement Concurrent use nitrate medication medication know interact Nitroglycerin sildenafil , treatment erectile dysfunction Patients know allergy Nitroglycerin common topical gel ingredient Patients history migraine , cluster vascular headache , suffer chronic pain Patients history unstable medical problem current condition would interfere participation study Patients unable complete pain assessment instruction Patients last three month myocardial infarction , uncontrolled congestive heart failure , unstable angina , uncontrolled hypotension uncontrolled hypertension Patients participate another investigational drug study within four week first study treatment Patients range laboratory screen value Patients major abdominal , thoracic vascular surgery within six month first study treatment Patients open lesion skin condition gel apply Pregnant nursing woman Women agree comply contraceptive requirement Patients history poor compliance , poor cooperation unreliability</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>Raynaud 's</keyword>
	<keyword>Nitroglycerin</keyword>
	<keyword>topical gel</keyword>
	<keyword>cold hand</keyword>
	<keyword>painful hand</keyword>
	<keyword>scleroderma</keyword>
</DOC>